E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/20/2015 in the Prospect News PIPE Daily.

Nymox Pharmaceutical seals $400,000 private placement of common stock

883,058 common shares sold at $0.453 each along with 441,529 warrants

By Devika Patel

Knoxville, Tenn., March 20 – Nymox Pharmaceutical Corp. said it completed a $400,000 private placement of stock.

The company sold 883,058 common shares at about $0.453 apiece. The price-per-share is a 17.64% discount to the March 19 closing share price of $0.55.

Investors also received warrants for 441,529 shares, exercisable at $2.00, a 263.64% premium to the March 19 closing price.

Nymox is a biotechnology company focused on needs of the aging population based in Hasbrouck, N.J.

Issuer:Nymox Pharmaceutical Corp.
Issue:Common stock
Amount:$400,000
Shares:883,058
Price:$0.453 (approximate)
Warrants:For 441,529 shares
Warrant strike price:$2.00
Settlement date:March 20
Stock symbol:Nasdaq: NYMX
Stock price:$0.55 at close March 19
Market capitalization:$19.59 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.